Rankings
▼
Calendar
IMA Q2 2022 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena
IMA
ImageneBio Inc
$69M
Q2 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$382,000
-89.2% YoY
Gross Profit
-$15M
-3954.5% margin
Operating Income
-$21M
-5484.6% margin
Net Income
-$20M
-5364.1% margin
EPS (Diluted)
$-0.55
QoQ Revenue Growth
-88.7%
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$19M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$211M
Total Liabilities
$37M
Stockholders' Equity
$174M
Cash & Equivalents
$48M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$382,000
$4M
-89.2%
Gross Profit
-$15M
-$8M
-93.0%
Operating Income
-$21M
-$13M
-65.1%
Net Income
-$20M
-$13M
-61.6%
← FY 2022
All Quarters
Q3 2022 →